Press releases

Here you can access to all press releases published by Heppe Medical Chitosan GmbH.

Press release mRNA active ingredients: Protected for an optimized effect

Written on 16 March 2023.

Berlin, Halle, 16.03.2023: Since January of this year, the project "Zielwirk" is developing a new chitosan technology for the efficient release of mRNA active ingredients. The technology aims to ensure that drugs for the treatment of serious diseases can be better absorbed as well as processed by the body. The participating project partners Heppe Medical Chitosan GmbH, FDX Fluid Dynamix GmbH, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Production Systems and Design Technology (IPK) are funded by the German Federal Ministry of Economics and Climate Protection (BMWK) with six million euros over three years.

drug delivery, chitosan, nanoparticles, science, Zielwirk, press release

HMC as a founding member of the new cluster initiative Life-Science Saxony-Anhalt

Written on 15 February 2023.

On November 16, 2022 the supporting association of the new cluster initiative Life-Science Saxony-Anhalt was founded in the technology park Weinberg Campus. We, the Heppe Medical Chitosan GmbH, are excited to be part of it as a founding member.

Weinberg Campus, Life Science

Heppe Medical Chitosan GmbH and High-Tech Gründerfonds on course of growth

Written on 09 July 2008.

The High-Tech Gründerfonds invests in Heppe Medical Chitosan GmbH, a developer and manufacturer of high purity biopolymers and nanoparticulate materials on chitin and chitosan basis.

News

Press releases

Press release mRNA active ingredients: Protected for an optimized effect

HMC as a founding member of the new cluster initiative Life-Science Saxony-Anhalt

Heppe Medical Chitosan GmbH and High-Tech Gründerfonds on course of growth

Congress and fairs

Contact

News